Donoghue Forlines’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
18,708
+3,954
+27% +$379K 0.45% 90
2025
Q4
$1.42M Sell
14,754
-1,357
-8% -$132K 0.44% 99
2025
Q3
$1.53M Sell
16,111
-620
-4% -$57K 0.47% 73
2025
Q2
$1.46M Buy
16,731
+826
+5% +$70K 0.42% 83
2025
Q1
$1.43M Sell
15,905
-2,923
-16% -$262K 0.45% 95
2024
Q4
$1.5M Buy
+18,828
New +$1.63M 0.5% 72
2019
Q4
Sell
-22,115
Closed -$2.4M 184
2019
Q3
$2.4M Buy
+22,115
New +$2.31M 0.34% 98

Other funds holding MDT

Donoghue Forlines's MDT Position: Q1 2026 in Review

Donoghue Forlines increased its Medtronic (MDT) stake by 27% in Q1 2026, buying an estimated $379K and bringing the position to 18,708 shares worth $1.62M. The position accounts for 0.45% of the portfolio, ranked #90.

Donoghue Forlines first reported a position in MDT in Q3 2019 and has held it in 7 quarters since. The position peaked at $2.4M in Q3 2019. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Donoghue Forlines held 18,708 shares of Medtronic worth $1.62M as of Q1 2026.
  • Donoghue Forlines bought 3,954 Medtronic shares in Q1 2026, an estimated $379K.
  • Medtronic made up 0.45% of Donoghue Forlines's portfolio in Q1 2026, its #90 holding.
  • Donoghue Forlines first reported a position in Medtronic in Q3 2019 and has held it in 7 quarters since.
  • Donoghue Forlines's Medtronic position peaked at $2.4M in Q3 2019.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.